Janus Kinase Inhibitor as a Potential Cause of Heart Block in a Case of Acute Severe Ulcerative Colitis in an Elderly

Janus Kinase Inhibitor as a Potential Cause of Heart Block in a Case of Acute Severe Ulcerative Colitis in an Elderly

Saved in:

Bibliographic Details
Main Authors:	Rakesh Holla, Uma N Saikia, Vishal Sharma, Sanjay Jain
Format:	Article
Language:	English
Published:	Jaypee Brothers Medical Publisher 2025-06-01
Series:	Journal of Postgraduate Medicine, Education and Research
Online Access:	https://www.jpmer.com/doi/JPMER/pdf/10.5005/jp-journals-10028-1731
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Janus Kinase Inhibitors in the Treatment of Crohn’s Disease and Ulcerative Colitis: A Review
by: Olimpia Wiciun, et al.
Published: (2025-05-01)

State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review
by: Yunseok Choi, et al.
Published: (2025-05-01)

Circular ribonucleic acid 0004104 as a potential biomarker and its relation to Janus kinase 2 in ulcerative colitis
by: Roaa Tarek Elbannan, et al.
Published: (2025-06-01)

Janus kinase inhibitors in the treatment of psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-02-01)

Intraocular infections following biologicals and Janus Kinase inhibitors
by: Parthopratim Dutta Majumder, et al.
Published: (2025-08-01)

Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?
by: Sarah E. Packer, et al.
Published: (2025-08-01)

Janus kinase inhibitors for alopecia areata: a review of clinical data
by: Yutong Sun, et al.
Published: (2025-05-01)

Loss of Cardiomyocyte Janus Kinase 1 (Jak1) Causes Cardiomyopathy
by: Arasakumar Subramani, et al.
Published: (2025-06-01)

Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
by: Jürgen Braun, et al.
Published: (2024-11-01)

Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors
by: Sebastian Hüper, et al.
Published: (2025-07-01)

Clinical significance of Janus kinase inhibitors in the therapy of rheumatoid arthritis: achievements and prospects
by: V. I. Mazurov, et al.
Published: (2019-10-01)

Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects
by: E. L. Nasonov, et al.
Published: (2019-03-01)

Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology
by: E. L. Nasonov, et al.
Published: (2022-05-01)

The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor
by: article Editorial
Published: (2023-03-01)

Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review
by: Yu Liu, et al.
Published: (2025-12-01)

Pharmacophore Modeling of Janus Kinase Inhibitors: Tools for Drug Discovery and Exposition Prediction
by: Florian Fischer, et al.
Published: (2025-05-01)

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
by: Ji Wen, et al.
Published: (2021-01-01)

Aggressive cutaneous squamous cell carcinoma in a patient on Janus-kinase inhibitor therapy
by: Ana M. Aragon Sierra, MD, et al.
Published: (2025-03-01)

Successful Treatment of Severe Nail Lichen Planus with Janus Kinase 1 Inhibitor Abrocitinib
by: Luo Y, et al.
Published: (2025-05-01)

Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case report
by: Molly Gunyon, et al.
Published: (2025-06-01)

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients
by: Shota Kurushima, et al.
Published: (2024-12-01)

Cardiovascular safety of Janus kinase inhibitors: A pharmacovigilance study from 2012-2023.
by: Xiaoyan Zhong, et al.
Published: (2025-01-01)

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)

Tumor necrosis factor inhibitors versus janus kinase inhibitors in patients with incomplete response to methotrexate in rheumatoid arthritis
by: Kunal Chandwar, et al.
Published: (2023-01-01)

The use of selective Janus kinase inhibitor upadacitinib in a patient with psoriatic arthritis (clinical observation)
by: Yu. A. Lushpaeva
Published: (2025-04-01)

Switching biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in patients with rheumatoid arthritis
by: A. O. Bobkova, et al.
Published: (2023-07-01)

Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
by: Chino Ogbutor, BA, et al.
Published: (2025-10-01)

A new trend in pathogenetic treatment of rheumatoid arthritis: tofacitinib, the first inhibitor of Janus kinase
by: Dmitry Evgenyevich Karateev
Published: (2014-03-01)

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol
by: Weiyu Ye, et al.
Published: (2025-08-01)

Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
by: Jin-Won Kwon, et al.
Published: (2024-04-01)

Refractory Segmental Hyaline Vasculitis Treated with Janus Kinase Inhibitor Tofacitinib: A Case Report
by: Zhang Y, et al.
Published: (2025-06-01)

Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles
by: Chunying Li, et al.
Published: (2025-01-01)

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report
by: Camille M. Powers, et al.
Published: (2024-12-01)

A case of pneumonia caused by infection with Tropheryma whipplei complicated by cryptococcus during treatment with a Janus kinase inhibitor: a case report
by: Xiaoxi Shan, et al.
Published: (2024-12-01)

A Novel Dual Bruton's Tyrosine Kinase/Janus Kinase 3 Inhibitor Wj1113 and its Therapeutic Effects on Rheumatoid Arthritis
by: Chunyu Zhang, et al.
Published: (2025-07-01)

Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series
by: Nina Vidic Krhlikar, et al.
Published: (2025-03-01)

Epigenomic landscapes define differential Janus kinases inhibitor sensitivity in IFN-γ-primed human macrophages
by: Geunho Kwon, et al.
Published: (2025-05-01)

Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
by: Grace Xiong, BHSc, et al.
Published: (2025-04-01)

Correction: comparison of active tuberculosis occurrence associated with janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
Published: (2024-12-01)

Neurological Adverse Events Associated with the Use of Janus Kinase Inhibitors: A Pharmacovigilance Study Based on Vigibase
by: Sunny Park, et al.
Published: (2025-03-01)